Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LMDX

LumiraDx (LMDX) Stock Price, News & Analysis

LumiraDx logo

About LumiraDx Stock (NASDAQ:LMDX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.0076
$0.0160
52-Week Range
N/A
Volume
132.24 million shs
Average Volume
56.75 million shs
Market Capitalization
$5.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LMDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LumiraDx and its competitors with MarketBeat's FREE daily newsletter.

LMDX Stock News Headlines

LumiraDx Ltd LMDXF
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
LMDX.O
Why Is LumiraDx (LMDX) Stock Down 13% Today?
See More Headlines

LMDX Stock Analysis - Frequently Asked Questions

LumiraDx Limited (NASDAQ:LMDX) announced its quarterly earnings data on Thursday, August, 24th. The company reported ($0.16) earnings per share for the quarter, missing analysts' consensus estimates of ($0.15) by $0.01. The business earned $21 million during the quarter, compared to the consensus estimate of $21.07 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that LumiraDx investors own include Predictive Oncology (POAI), Ford Motor (F), Bank of America (BAC), Abbott Laboratories (ABT), Wells Fargo & Company (WFC), JPMorgan Chase & Co. (JPM) and Wayfair (W).

Company Calendar

Last Earnings
8/24/2023
Today
7/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:LMDX
CIK
1685428
Fax
N/A
Employees
1,210
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.09)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$447.79 million
Net Margins
-268.45%
Pretax Margin
-264.58%
Return on Equity
N/A
Return on Assets
-77.91%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.45
Quick Ratio
0.23

Sales & Book Value

Annual Sales
$126.52 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.33) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
318,546,000
Free Float
205,749,000
Market Cap
$5.10 million
Optionable
Not Optionable
Beta
1.73
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:LMDX) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners